Early research (Phase 1)Study completedNCT01241682
What this trial is testing
Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma
Who this might be right for
Malignant (Pleural) Mesothelioma
Erasmus Medical Center 10